Timothy John Scannell's most recent trade in NovoCure Ltd was a trade of 16,697 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NovoCure Ltd | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 16,697 | 16,697 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 11,215 | 17,233 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | Timothy John Scannell | Director | Sale of securities on an exchange or to another person at price $ 17.32 per share. | 03 Jun 2025 | 999 | 6,018 (0%) | 0% | 17.3 | 17,299 | Ordinary Shares |
| Insulet | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 778 | 31,364 (0%) | 0% | 0 | Common Stock | |
| Masimo Corp | Timothy John Scannell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2025 | 1,383 | 0 | - | - | Restricted Stock Units | |
| Masimo Corp | Timothy John Scannell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2025 | 1,383 | 1,383 (0%) | 0% | 0 | Common Stock | |
| Masimo Corp | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2025 | 1,225 | 1,225 | - | - | Restricted Stock Units | |
| Masimo Corp | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Oct 2024 | 1,383 | 1,383 | - | - | Restricted Stock Units | |
| Insulet | Timothy John Scannell | Director | Sale of securities on an exchange or to another person at price $ 225.84 per share. | 10 Sep 2024 | 5,000 | 30,586 (0%) | 0% | 225.8 | 1,129,200 | Common Stock |
| Insulet | Timothy John Scannell | Director | Sale of securities on an exchange or to another person at price $ 190.51 per share. | 10 Jun 2024 | 7,000 | 35,586 (0%) | 0% | 190.5 | 1,333,570 | Common Stock |
| NovoCure Ltd | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 6,229 | 6,229 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 4,053 | 7,981 | - | 0 | Restricted Stock Units | |
| NovoCure Ltd | Timothy John Scannell | Director | Sale of securities on an exchange or to another person at price $ 23.89 per share. | 04 Jun 2024 | 964 | 2,964 (0%) | 0% | 23.9 | 23,027 | Ordinary Shares |
| Insulet | Timothy John Scannell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 5,525 | 0 | - | - | Stock Option (Right to Buy) | |
| Insulet | Timothy John Scannell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.37 per share. | 28 May 2024 | 5,525 | 37,064 (0%) | 0% | 27.4 | 151,219 | Common Stock |
| Insulet | Timothy John Scannell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 5,235 | 0 | - | - | Stock Option (Right to Buy) | |
| Insulet | Timothy John Scannell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.87 per share. | 28 May 2024 | 5,235 | 42,299 (0%) | 0% | 28.9 | 151,134 | Common Stock |
| Insulet | Timothy John Scannell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.38 per share. | 28 May 2024 | 3,920 | 31,539 (0%) | 0% | 36.4 | 142,610 | Common Stock |
| Insulet | Timothy John Scannell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 3,920 | 0 | - | - | Stock Option (Right to Buy) | |
| Insulet | Timothy John Scannell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 3,587 | 0 | - | - | Stock Option (Right to Buy) | |
| Insulet | Timothy John Scannell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.60 per share. | 28 May 2024 | 3,587 | 45,886 (0%) | 0% | 40.6 | 145,632 | Common Stock |
| Insulet | Timothy John Scannell | Director | Sale of securities on an exchange or to another person at price $ 180.90 per share. | 28 May 2024 | 3,300 | 42,586 (0%) | 0% | 180.9 | 596,970 | Common Stock |
| Insulet | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 1,380 | 27,619 (0%) | 0% | 0 | Common Stock | |
| NovoCure Ltd | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 6,277 | 6,277 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 3,853 | 3,928 | - | 0 | Restricted Stock Units | |
| Insulet | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 843 | 26,239 (0%) | 0% | 0 | Common Stock | |
| NovoCure Ltd | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 8,700 | 8,700 | - | - | Options to Buy Ordinary Shares | |
| Molekule Group Inc | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 55,289 | 55,289 | - | - | Restricted Stock Units | |
| Insulet | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 1,009 | 25,396 (0%) | 0% | 0 | Common Stock | |
| Molekule Group Inc | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 37,000 | 37,000 | - | - | Restricted Stock Units |